Predicting clinical benefit from everolimus in patients with advanced solid tumors, the CPCT-03 study

Fleur Weeber, Geert A. Cirkel, Marlous Hoogstraat, Sander Bins, Christa G.M. Gadellaa-van Hooijdonk, Salo Ooft, Erik van Werkhoven, Stefan M. Willems, Marijn van Stralen, Wouter B. Veldhuis, Nicolle J.M. Besselink, Hugo M. Horlings, Neeltje Steeghs, Maja J. de Jonge, Marlies H.G. Langenberg, Lodewyk F.A. Wessels, Edwin Cuppen, Edwin Cuppen, J.H. Schellens, Stefan SleijferMartijn P. Lolkema, Emile E. Voest*

*Corresponding author for this work

Research output: Contribution to journalArticleScientificpeer-review

9 Citations (Scopus)
47 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Predicting clinical benefit from everolimus in patients with advanced solid tumors, the CPCT-03 study'. Together they form a unique fingerprint.

INIS

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Neuroscience